These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9395545)

  • 1. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
    Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
    Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005.
    Burrows NR; Li Y; Williams DE
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):147-52. PubMed ID: 18334239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage renal disease in US minority groups.
    Feldman HI; Klag MJ; Chiapella AP; Whelton PK
    Am J Kidney Dis; 1992 May; 19(5):397-410. PubMed ID: 1585925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
    Lopes AA; Hornbuckle K; James SA; Port FK
    Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic renal disease: racial and ethnic differences from an epidemiologic perspective.
    Cowie CC
    Transplant Proc; 1993 Aug; 25(4):2426-30. PubMed ID: 8356621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess incidence of treatment of end-stage renal disease in Mexican Americans.
    Pugh JA; Stern MP; Haffner SM; Eifler CW; Zapata M
    Am J Epidemiol; 1988 Jan; 127(1):135-44. PubMed ID: 3276155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension.
    McClellan W; Tuttle E; Issa A
    Am J Kidney Dis; 1988 Oct; 12(4):285-90. PubMed ID: 3263042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The low birth weight hypothesis as a plausible explanation for the black/white differences in hypertension, non-insulin-dependent diabetes, and end-stage renal disease.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 Feb; 25(2):350-6. PubMed ID: 7847366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
    Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
    Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of end stage renal disease among low-income blacks and whites.
    Lipworth L; Mumma MT; Cavanaugh KL; Edwards TL; Ikizler TA; Tarone RE; McLaughlin JK; Blot WJ
    PLoS One; 2012; 7(10):e48407. PubMed ID: 23110237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
    Li S; McAlpine DD; Liu J; Li S; Collins AJ
    Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of end-stage renal disease in Georgia.
    McClellan W; Brogan D
    J Med Assoc Ga; 1990 Mar; 79(3):153-6. PubMed ID: 2319217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.